The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
Introduction <br/> Helminth infection may affect vaccine immunogenicity and efficacy. Adolescents, a target population for tuberculosis booster vaccines, often have a high helminth burden. We investigated effects of Schistosoma mansoni (Sm) on the immunogenicity and safety of MVA85A, a model c...
প্রধান লেখক: | Wajja, A, Kizito, D, Nassanga, B, Nalwoga, A, Kabagenyi, J, Kimuda, S, Galiwango, R, Mutonyi, G, Vermaak, S, Satti, I, Verweij, J, Tukahebwa, E, Cose, S, Levin, J, Kaleebu, P, Elliott, A, McShane, H |
---|---|
অন্যান্য লেখক: | Diemert, D |
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
Public Library of Science
2017
|
অনুরূপ উপাদানগুলি
-
The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
অনুযায়ী: Anne Wajja, অন্যান্য
প্রকাশিত: (2017-05-01) -
Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A
অনুযায়ী: Wajja, A, অন্যান্য
প্রকাশিত: (2018) -
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control
অনুযায়ী: Wajja, A, অন্যান্য
প্রকাশিত: (2024) -
Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A [version 1; referees: 1 approved, 2 approved with reservations]
অনুযায়ী: Anne Wajja, অন্যান্য
প্রকাশিত: (2018-09-01) -
Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial
অনুযায়ী: Wajja, A, অন্যান্য
প্রকাশিত: (2023)